Text Messaging Reminders for Influenza Vaccine in Primary Care
TXT4FLUJAB
A Feasibility Study for a Cluster Randomised Trial of Text Messaging Reminders for Influenza Vaccine in Patients Under 65 in Clinical Risk Groups in English Primary Care.
1 other identifier
interventional
156
1 country
1
Brief Summary
Influenza morbidity and mortality cause a substantial financial burden to the NHS and to the UK as a whole. Influenza vaccine is safe and effective but is required annually because the circulating strain of virus changes each year. In the UK in 2012, the Chief Medical Officer (CMO) recommended that at least 75% of elderly people (aged 65+) and 75% people under 65 with certain chronic conditions (e.g. chronic heart disease, diabetes, asthma, etc) should be vaccinated. While primary care practices are achieving these targets for elderly patients, those set for younger patients with chronic conditions are not being met, with a third of patients being missed in the 2011/12 flu season and with no substantial improvements in uptake in the past decade. Therefore strategies to increase flu vaccine uptake in these patients are required. Previous trials have shown that patient reminders can increase vaccine uptake and in particular, text messaging has shown to work in some populations in the United States as a cheap, simple and effective reminder. However, whether the same is true in UK general practice is unclear. The use of text messaging in the NHS for appointment reminders is also increasing as it is cheap, quick and effective. Text messaging is already used in roughly 30% of practices to remind patients about their flu vaccine but there has been no trial addressing its effectiveness. Therefore, we propose a trial of a text messaging flu vaccine reminder in patients aged under 65 who have a chronic condition. We hypothesise that practices that send a text message will have increased flu vaccine uptake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2013
CompletedFirst Posted
Study publicly available on registry
July 4, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedOctober 24, 2016
December 1, 2015
2.2 years
June 13, 2013
October 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients at risk who received flu vaccine
up to 9 months
Secondary Outcomes (4)
Proportion of practices reporting 'yes' to difficulties
up to 3 months
Recruitment rate
3 months after initial contact
Practice delivery of text message
One month after study start (October 1st 2013)
Were outcome data available
up to 9 months
Study Arms (2)
Standard care
OTHERPractices in the standard care arm will proceed with their seasonal influenza campaign as planned.
Text messaging intervention
EXPERIMENTALPractices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
Interventions
Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.
Eligibility Criteria
You may qualify if:
- practices must use text messaging software to communicate with patients;
- practices must not have used a text message to remind patients aged under 65 about influenza vaccine in the 2012/13 influenza season.
- practices will send the text message to eligible patients who are aged between 18 and 65, with one of the following risk conditions: chronic respiratory disease, chronic liver disease, chronic kidney disease, chronic heart disease, chronic neurological disease, immunosuppression
You may not qualify if:
- practices will not send the text message to pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- London School of Hygiene and Tropical Medicinelead
- Wellcome Trustcollaborator
- National Health Service, United Kingdomcollaborator
Study Sites (1)
London School of Hygiene and Tropical Medicine
London, Select County, WC1E 7HT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2013
First Posted
July 4, 2013
Study Start
September 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
October 24, 2016
Record last verified: 2015-12